These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29774583)

  • 1. Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Jul; 43(5):513-517. PubMed ID: 29774583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Aug; 43(6):659-666. PubMed ID: 29774587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions.
    Watad A; Amital H; Shoenfeld Y
    Lupus; 2017 Sep; 26(10):1015-1022. PubMed ID: 28420062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous system.
    Winkelmann A; Zettl UK
    Curr Pharm Des; 2012; 18(29):4570-82. PubMed ID: 22612749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolysis upon intravenous immunoglobulin transfusion.
    Padmore RF
    Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
    Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
    Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is intravenous immunoglobulin effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?].
    Navajas L; Rada G
    Medwave; 2014 Oct; 14(9):e6024. PubMed ID: 25340656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in serum hemoglobin, albumin, and electrolytes in patients receiving intravenous immunoglobulin therapy: a real clinical threat?
    Mignogna MD; Fortuna G; Ruoppo E; Adamo D; Leuci S; Fedele S
    Am J Clin Dermatol; 2007; 8(5):291-9. PubMed ID: 17902731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgIV at home:experience of a center--economic aspects].
    Hachulla E
    Rev Med Interne; 2007 May; 28 Spec No. 1():7-10. PubMed ID: 17768832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
    Lo MS; Newburger JW
    Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports.
    Padmore R
    Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoglobulins and physiopathology: actual indications].
    Mouthon L; Guilpain P
    Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].
    Fakhouri F
    Rev Med Interne; 2007 May; 28 Spec No. 1():4-6. PubMed ID: 17768831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
    Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinion regarding clinical and other outcome considerations in the formulary review of immune globulin.
    Sorensen R
    J Manag Care Pharm; 2007 Apr; 13(3):278-83. PubMed ID: 17407395
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it time to re-evaluate the treatment of pemphigus?
    Leventhal JS; Sanchez MR
    J Drugs Dermatol; 2012 Oct; 11(10):1200-6. PubMed ID: 23134985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.